Global Clinical Trial Supply Services 麻豆原创 Growth (Status and Outlook) 2024-2030

Publication ID:

LPI03244447

Publication Date:

March 21, 2024

Pages:

107

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Clinical Trial Supply Services market size was valued at US$ 1974.1 million in 2023. With growing demand in downstream market, the Clinical Trial Supply Services is forecast to a readjusted size of US$ 3519.4 million by 2030 with a CAGR of 8.6% during review period.
The research report highlights the growth potential of the global Clinical Trial Supply Services market. Clinical Trial Supply Services are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Clinical Trial Supply Services. 麻豆原创 players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Clinical Trial Supply Services market.
A safe clinical trial presupposes a robust supply chain management of the study drugs, consistent with various regional and global regulations and available infrastructures.
Safe clinical trials are premised on strong supply chain management of the investigational drug, in accordance with regional and global regulations, and in line with local production and development realities. Clinical trial consumable management is critical to avoid overproduction, inventory expiration, and oversupply.As the cost of drug development continues to rise, the supply of clinical trials is becoming ever more important.In addition, strict operational requirements for the implementation of a variety of biopharmaceutical products into clinical trials require constant reform of clinical trial supply strategies.This also requires the integration of multiple third party vendors at all stages of clinical development. Global Clinical Trial Supplies key players include Thermo Fisher Scientific, Catalent Pharma Solutions, Almac Group, Parexel International, UDG Healthcare etc. China top five manufacturers hold a Production Share over 70%. North America accounts for the most Sales 麻豆原创 Share, which have a share over 50%, followed by Europe. In terms of product, Supply Chain Management is the largest segment, with a 麻豆原创 Share over 35%. And in terms of application, the largest Application is Clinical Phase iii.
Key Features:
The report on Clinical Trial Supply Services market reflects various aspects and provide valuable insights into the industry.
麻豆原创 Size and Growth: The research report provide an overview of the current size and growth of the Clinical Trial Supply Services market. It may include historical data, market segmentation by Type (e.g., Manufacturing, Packaging and Labeling), and regional breakdowns.
麻豆原创 Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Clinical Trial Supply Services market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Clinical Trial Supply Services market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Clinical Trial Supply Services industry. This include advancements in Clinical Trial Supply Services technology, Clinical Trial Supply Services new entrants, Clinical Trial Supply Services new investment, and other innovations that are shaping the future of Clinical Trial Supply Services.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Clinical Trial Supply Services market. It includes factors influencing customer ' purchasing decisions, preferences for Clinical Trial Supply Services product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Clinical Trial Supply Services market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Clinical Trial Supply Services market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Clinical Trial Supply Services market.
麻豆原创 Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Clinical Trial Supply Services industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Clinical Trial Supply Services market.
麻豆原创 Segmentation:
Clinical Trial Supply Services market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Manufacturing
Packaging and Labeling
Logistics and Distribution
Segmentation by application
Oncology
Cardiovascular Diseases
Respiratory Diseases
CNS And Mental Disorders
Dermatology
Blood Disorders
Infectious Diseases
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Parexel International
ALMAC Group
Catalent Pharma Solutions
Piramal Pharma Solutions
Shertech Manufacturing
Thermo Fisher Scientific
PCI Services
Patheon, Inc.
Sharp Packaging Services
Biocair
Movianto
Klifo A/S.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Clinical Trial Supply Services 麻豆原创 Size 2019-2030
2.1.2 Clinical Trial Supply Services 麻豆原创 Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Clinical Trial Supply Services Segment by Type
2.2.1 Manufacturing
2.2.2 Packaging and Labeling
2.2.3 Logistics and Distribution
2.3 Clinical Trial Supply Services 麻豆原创 Size by Type
2.3.1 Clinical Trial Supply Services 麻豆原创 Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Clinical Trial Supply Services 麻豆原创 Size 麻豆原创 Share by Type (2019-2024)
2.4 Clinical Trial Supply Services Segment by Application
2.4.1 Oncology
2.4.2 Cardiovascular Diseases
2.4.3 Respiratory Diseases
2.4.4 CNS And Mental Disorders
2.4.5 Dermatology
2.4.6 Blood Disorders
2.4.7 Infectious Diseases
2.4.8 Others
2.5 Clinical Trial Supply Services 麻豆原创 Size by Application
2.5.1 Clinical Trial Supply Services 麻豆原创 Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Clinical Trial Supply Services 麻豆原创 Size 麻豆原创 Share by Application (2019-2024)
3 Clinical Trial Supply Services 麻豆原创 Size by Player
3.1 Clinical Trial Supply Services 麻豆原创 Size 麻豆原创 Share by Players
3.1.1 Global Clinical Trial Supply Services Revenue by Players (2019-2024)
3.1.2 Global Clinical Trial Supply Services Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Clinical Trial Supply Services Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Clinical Trial Supply Services by Regions
4.1 Clinical Trial Supply Services 麻豆原创 Size by Regions (2019-2024)
4.2 Americas Clinical Trial Supply Services 麻豆原创 Size Growth (2019-2024)
4.3 APAC Clinical Trial Supply Services 麻豆原创 Size Growth (2019-2024)
4.4 Europe Clinical Trial Supply Services 麻豆原创 Size Growth (2019-2024)
4.5 Middle East & Africa Clinical Trial Supply Services 麻豆原创 Size Growth (2019-2024)
5 Americas
5.1 Americas Clinical Trial Supply Services 麻豆原创 Size by Country (2019-2024)
5.2 Americas Clinical Trial Supply Services 麻豆原创 Size by Type (2019-2024)
5.3 Americas Clinical Trial Supply Services 麻豆原创 Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Clinical Trial Supply Services 麻豆原创 Size by Region (2019-2024)
6.2 APAC Clinical Trial Supply Services 麻豆原创 Size by Type (2019-2024)
6.3 APAC Clinical Trial Supply Services 麻豆原创 Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Clinical Trial Supply Services by Country (2019-2024)
7.2 Europe Clinical Trial Supply Services 麻豆原创 Size by Type (2019-2024)
7.3 Europe Clinical Trial Supply Services 麻豆原创 Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Clinical Trial Supply Services by Region (2019-2024)
8.2 Middle East & Africa Clinical Trial Supply Services 麻豆原创 Size by Type (2019-2024)
8.3 Middle East & Africa Clinical Trial Supply Services 麻豆原创 Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Clinical Trial Supply Services 麻豆原创 Forecast
10.1 Global Clinical Trial Supply Services Forecast by Regions (2025-2030)
10.1.1 Global Clinical Trial Supply Services Forecast by Regions (2025-2030)
10.1.2 Americas Clinical Trial Supply Services Forecast
10.1.3 APAC Clinical Trial Supply Services Forecast
10.1.4 Europe Clinical Trial Supply Services Forecast
10.1.5 Middle East & Africa Clinical Trial Supply Services Forecast
10.2 Americas Clinical Trial Supply Services Forecast by Country (2025-2030)
10.2.1 United States Clinical Trial Supply Services 麻豆原创 Forecast
10.2.2 Canada Clinical Trial Supply Services 麻豆原创 Forecast
10.2.3 Mexico Clinical Trial Supply Services 麻豆原创 Forecast
10.2.4 Brazil Clinical Trial Supply Services 麻豆原创 Forecast
10.3 APAC Clinical Trial Supply Services Forecast by Region (2025-2030)
10.3.1 China Clinical Trial Supply Services 麻豆原创 Forecast
10.3.2 Japan Clinical Trial Supply Services 麻豆原创 Forecast
10.3.3 Korea Clinical Trial Supply Services 麻豆原创 Forecast
10.3.4 Southeast Asia Clinical Trial Supply Services 麻豆原创 Forecast
10.3.5 India Clinical Trial Supply Services 麻豆原创 Forecast
10.3.6 Australia Clinical Trial Supply Services 麻豆原创 Forecast
10.4 Europe Clinical Trial Supply Services Forecast by Country (2025-2030)
10.4.1 Germany Clinical Trial Supply Services 麻豆原创 Forecast
10.4.2 France Clinical Trial Supply Services 麻豆原创 Forecast
10.4.3 UK Clinical Trial Supply Services 麻豆原创 Forecast
10.4.4 Italy Clinical Trial Supply Services 麻豆原创 Forecast
10.4.5 Russia Clinical Trial Supply Services 麻豆原创 Forecast
10.5 Middle East & Africa Clinical Trial Supply Services Forecast by Region (2025-2030)
10.5.1 Egypt Clinical Trial Supply Services 麻豆原创 Forecast
10.5.2 South Africa Clinical Trial Supply Services 麻豆原创 Forecast
10.5.3 Israel Clinical Trial Supply Services 麻豆原创 Forecast
10.5.4 Turkey Clinical Trial Supply Services 麻豆原创 Forecast
10.5.5 GCC Countries Clinical Trial Supply Services 麻豆原创 Forecast
10.6 Global Clinical Trial Supply Services Forecast by Type (2025-2030)
10.7 Global Clinical Trial Supply Services Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Parexel International
11.1.1 Parexel International Company Information
11.1.2 Parexel International Clinical Trial Supply Services Product Offered
11.1.3 Parexel International Clinical Trial Supply Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.1.4 Parexel International Main Business Overview
11.1.5 Parexel International Latest Developments
11.2 ALMAC Group
11.2.1 ALMAC Group Company Information
11.2.2 ALMAC Group Clinical Trial Supply Services Product Offered
11.2.3 ALMAC Group Clinical Trial Supply Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.2.4 ALMAC Group Main Business Overview
11.2.5 ALMAC Group Latest Developments
11.3 Catalent Pharma Solutions
11.3.1 Catalent Pharma Solutions Company Information
11.3.2 Catalent Pharma Solutions Clinical Trial Supply Services Product Offered
11.3.3 Catalent Pharma Solutions Clinical Trial Supply Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.3.4 Catalent Pharma Solutions Main Business Overview
11.3.5 Catalent Pharma Solutions Latest Developments
11.4 Piramal Pharma Solutions
11.4.1 Piramal Pharma Solutions Company Information
11.4.2 Piramal Pharma Solutions Clinical Trial Supply Services Product Offered
11.4.3 Piramal Pharma Solutions Clinical Trial Supply Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.4.4 Piramal Pharma Solutions Main Business Overview
11.4.5 Piramal Pharma Solutions Latest Developments
11.5 Shertech Manufacturing
11.5.1 Shertech Manufacturing Company Information
11.5.2 Shertech Manufacturing Clinical Trial Supply Services Product Offered
11.5.3 Shertech Manufacturing Clinical Trial Supply Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.5.4 Shertech Manufacturing Main Business Overview
11.5.5 Shertech Manufacturing Latest Developments
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Information
11.6.2 Thermo Fisher Scientific Clinical Trial Supply Services Product Offered
11.6.3 Thermo Fisher Scientific Clinical Trial Supply Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.6.4 Thermo Fisher Scientific Main Business Overview
11.6.5 Thermo Fisher Scientific Latest Developments
11.7 PCI Services
11.7.1 PCI Services Company Information
11.7.2 PCI Services Clinical Trial Supply Services Product Offered
11.7.3 PCI Services Clinical Trial Supply Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.7.4 PCI Services Main Business Overview
11.7.5 PCI Services Latest Developments
11.8 Patheon, Inc.
11.8.1 Patheon, Inc. Company Information
11.8.2 Patheon, Inc. Clinical Trial Supply Services Product Offered
11.8.3 Patheon, Inc. Clinical Trial Supply Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.8.4 Patheon, Inc. Main Business Overview
11.8.5 Patheon, Inc. Latest Developments
11.9 Sharp Packaging Services
11.9.1 Sharp Packaging Services Company Information
11.9.2 Sharp Packaging Services Clinical Trial Supply Services Product Offered
11.9.3 Sharp Packaging Services Clinical Trial Supply Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.9.4 Sharp Packaging Services Main Business Overview
11.9.5 Sharp Packaging Services Latest Developments
11.10 Biocair
11.10.1 Biocair Company Information
11.10.2 Biocair Clinical Trial Supply Services Product Offered
11.10.3 Biocair Clinical Trial Supply Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.10.4 Biocair Main Business Overview
11.10.5 Biocair Latest Developments
11.11 Movianto
11.11.1 Movianto Company Information
11.11.2 Movianto Clinical Trial Supply Services Product Offered
11.11.3 Movianto Clinical Trial Supply Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.11.4 Movianto Main Business Overview
11.11.5 Movianto Latest Developments
11.12 Klifo A/S.
11.12.1 Klifo A/S. Company Information
11.12.2 Klifo A/S. Clinical Trial Supply Services Product Offered
11.12.3 Klifo A/S. Clinical Trial Supply Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.12.4 Klifo A/S. Main Business Overview
11.12.5 Klifo A/S. Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.